In The News

Life Sciences Attorney Discusses Off-Label Drug Promotion in New York Times

Practices: Life Sciences

On May 7, an article in The New York Times titled “Drugmaker Sues F.D.A. Over Right to Discuss Off-Label Uses” featured quotes from life sciences counsel Kellie Combs (Washington, DC) on off-label speech in the context of a First Amendment lawsuit filed by Amarin Pharmaceuticals against the Food and Drug Administration. The case concerns the legality of communications between drug companies and physicians regarding the off-label use of drugs.

Cookie Settings